CELECOXIB SPE2D2-20-R-0075
Summary
AI-generated · Aug 24, 2025Modification to announce exercising the third option year for celecoxib under the existing contract.
The notice does not provide additional requirements, scope, quantities, or delivery details beyond noting the option-year exercise.
Modification to announce exercising 3rd option year.
From Solicitation posted on Jun 05, 2025Notice history
1-
Solicitation LATEST Posted Jun 05, 2025
Details
Award Information
Not yet awarded
Contacts
Phone
Phone